4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-22-009348
CHIEF FINANCIAL OFFICER gave up 547 shares (to pay taxes)
- CHIEF FINANCIAL OFFICER acquired 1,861 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ragosa Mark CHIEF FINANCIAL OFFICER | 2022-09-02 | Option exercise | +1,861 | 8,218 | D | ||
| Ragosa Mark CHIEF FINANCIAL OFFICER | 2022-09-02 | Shares withheld for taxes | −547 | $11.44 | $6,258 | 7,671 | D |
| Derivatives | |||||||
| Ragosa Mark CHIEF FINANCIAL OFFICER | 2022-09-01 | Grant or award · Share Option | +64,660 | 64,660 | D | ||
| Ragosa Mark CHIEF FINANCIAL OFFICER | 2022-09-01 | Grant or award · Restricted Share Unit | +10,777 | 10,777 | D | ||
| Ragosa Mark CHIEF FINANCIAL OFFICER | 2022-09-02 | Option exercise · Restricted Share Unit | −1,861 | 5,583 | D | ||
Loading xslF345X03/form4-09062022_010947.xml…